DisGeNET

DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.

Source Last Updated
DisGeNET July 29, 2024
Displaying entries 11876 - 11900 of 62743 in total
Disease ID Disease Name Gene Symbol Gene ID ▲ Gene Name UniProt ID
C0005684 Malignant neoplasm of urinary bladder AGL 178 amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase P35573
C0021051 Immunologic Deficiency Syndromes AGL 178 amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase P35573
C0025517 Metabolic Diseases AGL 178 amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase P35573
C0271694 Familial partial lipodystrophy AGL 178 amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase P35573
C0030326 Panniculitis AGL 178 amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase P35573
C0023487 Acute Promyelocytic Leukemia AGL 178 amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase P35573
C1859592 ATRICHIA WITH PAPULAR LESIONS AGL 178 amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase P35573
C0241005 Creatine phosphokinase serum increased AGL 178 amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase P35573
C0239946 Fibrosis, Liver AGL 178 amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase P35573
C0023787 Lipodystrophy AGL 178 amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase P35573
C0013336 Dwarfism AGL 178 amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase P35573
C0019196 Hepatitis C AGL 178 amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase P35573
C0017921 Glycogen storage disease type II AGL 178 amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase P35573
C0020473 Hyperlipidemia AGL 178 amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase P35573
C0007131 Non-Small Cell Lung Carcinoma AGL 178 amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase P35573
C0699790 Colon Carcinoma AGL 178 amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase P35573
C0751882 Myasthenic Syndromes, Congenital DPAGT1 1798 dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 Q9H3H5
C3714756 Intellectual Disability DPAGT1 1798 dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 Q9H3H5
C3553645 MYASTHENIC SYNDROME, CONGENITAL, 13 DPAGT1 1798 dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 Q9H3H5
C0520947 Clumsiness - motor delay DPAGT1 1798 dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 Q9H3H5
C0026848 Myopathy DPAGT1 1798 dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 Q9H3H5
C0282577 Congenital Disorders of Glycosylation DPAGT1 1798 dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 Q9H3H5
C0015310 Exotropia DPAGT1 1798 dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 Q9H3H5
C4317295 Congenital disorder of glycosylation type 1s DPAGT1 1798 dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 Q9H3H5
C0024623 Malignant neoplasm of stomach DPAGT1 1798 dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 Q9H3H5

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024